isosorbide dinitrate has been researched along with HbS Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosquesi, PL; Cerecetto, H; Chelucci, RC; Chung, MC; Costa, FF; Dos Santos, JL; Gambero, S; González, M; Lanaro, C; Lima, LM; Reis, JS | 1 |
| Barbieri, KP; Capote, TSO; Carlos, IZ; Chegaev, K; Chelucci, RC; Chung, MC; Coelho, F; Costa, FF; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Kumkhaek, C; Lanaro, C; Lopes Pires, ME; Marcondes, S; Melo, TRF; Rodgers, GP | 1 |
2 other study(ies) available for isosorbide dinitrate and HbS Disease
| Article | Year |
|---|---|
Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. part II: furoxan derivatives.
Topics: Anemia, Sickle Cell; Drug Design; Drug Evaluation, Preclinical; Humans; Nitric Oxide Donors; Oxadiazoles; Polymerase Chain Reaction | 2012 |
Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation.
Topics: Acetic Acid; Acetylation; Anemia, Sickle Cell; Dose-Response Relationship, Drug; Drug Discovery; gamma-Globins; Histones; Humans; K562 Cells; Molecular Structure; Nitric Oxide; Oxadiazoles; Structure-Activity Relationship | 2018 |